Noradrenaline Aguettant (Noradrenaline Tartrate)

Noradrenaline, the active ingredient in Noradrenaline Aguettant, is a vasopressor presented as an injection for intravenous use. It is employed to raise blood pressure in patients experiencing hypotension, various forms of shock, or cardiac arrest, particularly in critical care environments.

GNH USA supplies Noradrenaline Aguettant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable logistics for critical care medicines across global markets. Clients benefit from consistent product availability and regulatory support.

Noradrenaline is a sympathomimetic vasopressor used in acute circulatory failure.

- Hypotension: restores arterial pressure by inducing vasoconstriction in patients with low blood pressure. - Shock: improves systemic vascular resistance to support perfusion in various shock states. - Cardiac arrest: provides pressor support during resuscitation efforts to maintain coronary perfusion.

Noradrenaline may be associated with a range of adverse reactions, varying from frequent to rare.

Common Side Effects: - Headache: transient cranial discomfort due to vasoconstriction. - Tremor: mild shaking of limbs. - Nausea: occasional gastrointestinal upset. - Palpitations: sensation of rapid heartbeat. - Anxiety: heightened nervousness. - Skin pallor: paleness due to peripheral vasoconstriction.

Serious or Rare Side Effects: - Severe hypertension: excessive rise in blood pressure that may cause vascular injury. - Ischemic limb events: reduced blood flow leading to pain or tissue damage. - Cardiac arrhythmias: abnormal heart rhythms including ventricular tachycardia. - Myocardial ischemia: chest pain from reduced coronary perfusion. - Tissue necrosis: severe peripheral ischemia resulting in skin breakdown. - Pulmonary edema: fluid accumulation in lungs due to abrupt pressure changes.

When using Noradrenaline, clinicians should observe specific safety measures to minimize risks. - Dose titration: adjust infusion rate based on continuous blood pressure monitoring. - Cardiac monitoring: observe for arrhythmias and ischemic changes during therapy. - Peripheral perfusion: assess limb circulation regularly to detect ischemia. - Drug compatibility: verify compatibility with IV fluids and other vasoactive agents. - Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Noradrenaline can interact with other medications, affecting its efficacy or safety.

Major Interactions (Avoid): - Beta‑blockers: may blunt the pressor response, reducing effectiveness. - Monoamine oxidase inhibitors (MAOIs): increase risk of hypertensive crisis. - Tricyclic antidepressants: potentiate vasoconstrictive effects, raising blood pressure excessively.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: may enhance hypotensive effects if abrupt withdrawal occurs. - Vasodilators (e.g., nitroglycerin): may counteract noradrenaline’s pressor action, requiring dose adjustments. - Diuretics: can exacerbate volume depletion, influencing hemodynamic response.